A series of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives has been synthesized and assayed for their ability to inhibit the activity of the A and B isoforms of human monoamine oxidase (hMAO). Some of these compounds were endowed with a selective inhibitory activity against hMAO-B in the micromolar range. The most active of the series is the compound 13, N1-thiocarbamoyl-3-(fur-2'-yl)-5-(4'-fluoro-phenyl)-4,5-dihydro-(1H)-pyrazole, with IC(50) 2.75+/-0.81muM value and selectivity ratio of 25, which is the best candidate for further investigations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejmech.2009.11.003 | DOI Listing |
Publication Analysis
Top Keywords
inhibitory activity
8
human monoamine
8
monoamine oxidase
8
n1-thiocarbamoyl-35-diheteroaryl-45-dihydro-1h-pyrazole derivatives
8
synthesis inhibitory
4
activity human
4
oxidase n1-thiocarbamoyl-35-diheteroaryl-45-dihydro-1h-pyrazole
4
derivatives series
4
series n1-thiocarbamoyl-35-diheteroaryl-45-dihydro-1h-pyrazole
4
derivatives synthesized
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!